Laddar...
Elevated hepatocyte growth factor expression as an autocrine c‐Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and the third leading cause of cancer‐related deaths worldwide. Limitations in HCC treatment result due to poor prognosis and resistance against traditional radiotherapy and chemotherapies. The multikinase inhibitor soraf...
Sparad:
| I publikationen: | Cancer Sci |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4832867/ https://ncbi.nlm.nih.gov/pubmed/26790028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12891 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|